Melinda French Gates has announced a $100 million investment into women’s health through a partnership between Pivotal (the coalition...

Using generative AI to discover new antibiotics On 14 August 2025, the Massachusetts Institute of Technology (MIT) reported1 that a team...

In another welcome development, the MHRA has published an interesting Statement of Policy Intent for Early Access Service to Innovative...

Healthcare generally is a priority enforcement sector for competition watchdogs across the world, including the UK’s Competition and...

University spin-out companies offer a means of commercialising valuable intellectual property (IP) and technology generated through...

On 22 July 2025, the UK Government signalled that it is likely to pivot back to indefinite recognition of CE Marking of devices. In a...

AI presents many opportunities in the women’s health space, but it can also pose considerable risks. Anyone seeking to commercialise...

Although the UK’s new R&D tax relief regime came into force on 1 April 2024, many companies have only now completed their first...

At the start of the year, our editors (Xisca Borrás, Katie Cambrook and Aida Tohala) presented to you the 12th edition of our Biotech...

Earlier this year, we reported on key considerations that parties involved in the negotiation and drafting of financial milestone...

On Wednesday, the Court of Appeal handed down a decision upholding Astellas’ enzalutamide patent. Appeals on the question of obviousness...

Government launches consultation into its national security notification regime which could see a shake up to key sensitive sectors to...